Pharmaceutical Executive September 10, 2024

AI is a tool to make drug discovery cheaper, faster, and better — not a replacement for human ingenuity.

The AI revolution is shaping numerous facets of our lives. While advancements by OpenAI and Anthropic plus NVIDIA’s market performance have commanded a significant portion of media attention, the overall impact of advanced computational methods in biopharma has been largely underreported. On the front lines of drug development, a combination of AI with computational modelling and bioinformatics has become fundamental for the advancement of drug development research we’ve seen over the last decade.

Drug discovery has historically been a long, inefficient and protracted process, heavily reliant on serendipity, often tedious persistence and, good ole’-fashioned trial and error. This meant time. Lots...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Set Your Team Up to Collaborate with AI Successfully
What’s So Great About Nvidia Blackwell?
Mayo develops new AI tools
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article